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Abstract
Background: This study is part of a series of process evaluations within the MOSAIC Trial (Maudsley Outpatient
Study of Treatments for Anorexia Nervosa and Related Conditions). This randomised controlled trial (RCT) compared
two psychological treatments, the Maudsley Model for Treatment of Adults with Anorexia Nervosa (MANTRA) and
Specialist Supportive Clinical Management (SSCM) for adult outpatients with Anorexia Nervosa. The present process
study integrates quantitative (treatment acceptability and credibility) and qualitative (written) feedback to evaluate
patients’ treatment experiences.
Method: All 142 MOSAIC participants were asked to (a) rate treatment acceptability and credibility on visual
analogue scales (VAS) at six and 12 months post-randomisation, and (b) provide written feedback regarding their
views on their treatment at 12 months. Transcripts were first analysed thematically and then rated according to the
global valence of feedback (positive, mixed/negative).
Results: 114/142 (80.3 %) MOSAIC participants provided VAS data and 82 (57.7 %) provided written feedback.
At 12 months, MANTRA patients gave significantly higher acceptability and credibility ratings compared to SSCM
patients. A significantly higher proportion of MANTRA patients provided written feedback. MANTRA patients also
tended to write in more detail and to give globally more positive feedback when compared to individuals receiving
SSCM. Qualitative themes suggest that patients experienced the two treatments differently in terms of
characteristics and outcomes.
Conclusions: This study highlights the benefits of incorporating qualitative and quantitative data into RCT process
evaluations. MANTRA patients were more willing to express their views on treatment and generally felt more
positively about this than those receiving SSCM.
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Background
Anorexia nervosa (AN) is a highly debilitating mental
disorder which is challenging to treat and expensive to
manage, especially in adults with a more enduring form
of the illness [1]. The UK National Institute for Health
and Care Excellence [2] and the US National Institute of
Mental Health [3] have emphasized the need for the de-
velopment and evaluation of new approaches to the
treatment of AN as at present, there is little high quality
empirical evidence to support a preferred psychological
treatment [4].
Whilst randomised controlled trials (RCTs) remain the
gold standard for evaluating treatment outcomes, process
evaluations integrated into trials provide crucial informa-
tion regarding factors involved in treatment success, such
as fidelity and quality of implementation, potential causal
mechanisms, and contextual factors associated with vari-
ation in outcomes [5]. Such process evaluations are used
to supplement quantitative outcomes by providing a
more complete picture of the treatment approach [6].
This puts an emphasis on meanings, experiences, and
views of all the participants in order to understand
treatment in the natural setting [7]. Evaluations aim to
identify the potential “active ingredients” of a particular
treatment approach, and explore interactions between
patients and therapists [6].
The present study is the second stage of a planned
process evaluation conducted as part of a large multi-
centre RCT, the Maudsley Outpatient Study of Treat-
ment for Adults with Anorexia Nervosa and Related
Conditions (MOSAIC). The MOSAIC trial compared two
outpatient treatments. The first is a novel therapy, Mauds-
ley Model of Treatment for Adults with Anorexia Nervosa
(MANTRA) [8–10], and the second, Specialist Supportive
Clinical Management (SSCM) is a more established
treatment that was developed as a standardised form of
treatment as usual, emphasising the importance of the
non-specific curative factors of therapeutic relation-
ships and active interest of the therapists in the pro-
gress of their patients. This treatment has been shown
to be superior to cognitive behavioral therapy and
interpersonal psychotherapy at end of treatment [11],
but with effects lessening over time [12, 13]. Full details
on the MOSAIC trial [14], MANTRA [8–10, 15, 16]
and SSCM [11, 17] can be found elsewhere. Both treat-
ments were found to be effective, with MANTRA hav-
ing advantages in more severely ill patients [18].
In the first stage of our process evaluation, we
explored both therapist and patient experiences of
MANTRA and SSCM using in-depth qualitative inter-
views [19, 20]. There was a high level of agreement be-
tween therapists’ and patients’ views of these two
treatments, their unique and overlapping features and
relative strengths and weaknesses.
A limitation of the study on patients’ views [19] was
that because of resource constraints only a small propor-
tion (n = 17) of participants from one of the study cen-
tres were included and they were interviewed at
different stages of treatment, i.e. without the benefit of
having experienced a full course of treatment. Oakley
et al. [21] have highlighted several methodological issues
to be considered in conducting process evaluations
within RCTs: All participating treatment sites should be
included as well as both qualitative and quantitative
data, and importantly, process data should be analysed
prior to the outcome data to minimize potential biases
in interpreting results. The present study has taken into
account the aforementioned criteria, in addition to ap-
proaching all available MOSAIC trial patients to obtain
generalisable results and assessing their feedback after
the completion of all treatment sessions, in order to sup-
plement the earlier study by Lose et al. [19].
Accordingly, the aim of the current study was to con-
duct a process evaluation prior to analysis of outcome
data to investigate patients’ experiences of two different
treatments within a large RCT of outpatient treatment
of AN. The main objective was to combine participants’
quantitative treatment acceptability and credibility rat-
ings at 12 months with qualitative written feedback. It
was hoped that the patients’ qualitative feedback could
shed more light on the factors associated with their
treatment ratings.
Materials and Method
Participants
MOSAIC trial participants were 142 adults (98 % fe-
male) with a DSM-IV-TR (2000) diagnosis of AN or
Eating Disorder Not Otherwise Specified AN type
(EDNOS-AN), recruited between June 2010 and
November 2012 from four treatment centres in the UK:
South London and Maudsley NHS Foundation Trust;
North East London Foundation Trust Eating Disorders
Service; Barnet, Enfield & Haringey Mental Health
NHS Trust; Oxford Health NHS Foundation Trust. For
inclusion in the trial, participants needed a body mass
index (BMI) of below 18.5 kg/m2 and the absence of
any major mental or physical co-morbidities that war-
ranted their own treatment. There was no lower BMI
limit provided patients were medically stable. After ini-
tial assessment, including a range of eating disorder
(ED) and other outcome measures, participants were
randomly allocated to receive either 20 once-weekly
sessions of MANTRA or SSCM plus four monthly
follow-up sessions. Optional additional sessions with a
dietician and sessions including a family member were
also offered. Patients with a BMI of ≤ 15 kg/m2 at the
start of treatment were offered 30 weekly sessions.
Therapists were expected to see patients in both
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treatment conditions to control for therapist effects.
Follow-up research assessments were carried out at six
months (approximately at the end of weekly treatment
sessions) and 12 months (end of follow-up sessions).
Full details of in- and exclusion criteria and trial proce-
dures can be found elsewhere [14].
Informed consent was obtained from all individual
participants included in the study. Ethical approval for
the MOSAIC trial was obtained from the Central
London REC 4, National Research Ethics Service,
Royal Free Hospital, London, (Reference: 10/H0714/
9). The trial is registered with Current Controlled Tri-
als: ISRCTN67720902.
Measures
Eating Disorders Examination (EDE) [22]
The EDE measures eating disordered thoughts and
behaviors. The EDE is a semi-structured diagnostic
interview that generates 4 subscale scores, the mean of
which gives an overall global score. Higher scores indi-
cate more serious eating disordered psychopathology. It
has been shown to have good reliability and discriminant
validity [23, 24]. EDE interviews were carried out by
trained assessors. Inter-rater reliability was checked
through second scoring every 10th interview.
Treatment acceptability and credibility
Acceptability and credibility of treatment were assessed
using two 10 cm visual analogue scales (VAS). Partici-
pants were asked to place a vertical mark on each scale
to indicate how they would rate themselves in relation
to two questions: 1) ‘How acceptable did you find the
type of treatment you received from your therapist dur-
ing this study?’ and 2) ‘To what extent do you feel that
the treatment you received has helped you to reduce
your eating disorder behaviors?’ On the two scales, 0 cm
corresponds to ‘completely unacceptable’ and ‘not at all’
and 10 cm represents ‘completely acceptable’ and ‘very
much so’ respectively. As a treatment’s ‘credibility’ may
be difficult for patients to conceptualize, we operationa-
lised it as the reduction of eating disorder behaviours to
assess how the treatment has been effective. Helpfulness
of treatment is a key aspect of established credibility
scales [25]. Scores for treatment acceptability and treat-
ment credibility were calculated separately and to one
decimal place.
Participant written feedback form
This qualitative feedback form asked two questions: (1)
‘What was your experience of therapy in the MOSAIC
trial?’ and (2) ‘Do you have any comments or sugges-
tions?’ Participants were informed that anonymised
quotes might be used in publications and a tick box
was provided if participants wished to opt out from this
(2/82 participants used this option). To protect ano-
nymity, all participants who completed the written
feedback were assigned a pseudonym.
Procedure
Demographic and clinical information including age, age
of onset, illness duration, BMI, and EDE global score
were collected at baseline (pre-randomisation) assess-
ment. Process evaluation data were part of the planned
6- and 12 month follow-up assessments. Ratings of
acceptability and credibility were obtained at both 6-
and 12-month follow-up assessments in order to cap-
ture changing views over time. Written feedback was
collected at 12 months only. In all cases, participants
were posted the process questionnaires to complete in
their own time prior to attending the planned follow-
up appointment.
At the time of data collection, research assessors did
not read written feedback forms in order to ensure
they remained blind to patient treatment allocation.
Instead a separate researcher (KAZ), who was not in-
volved in data collection, read and transcribed the
feedback for analysis.
Data analysis
Quantitative analysis
Analyses were conducted with IBM SPSS Statistics
Version 20 software. Baseline demographic and clinical
characteristics were compared between the two treat-
ment groups and between patients who did or did not
provide process evaluation data. Independent t-tests
were conducted to compare the acceptability and cred-
ibility ratings given by MANTRA and SSCM patients at
6-month and12-month follow up assessments.
Qualitative analysis
Participants’ written feedback forms were transcribed
verbatim and imported into NVivo 10 by researcher
KAZ. Data were analysed using Braun and Clarke’s [26]
six phase thematic analysis process from a realist epis-
temological standpoint. The approach used is similar to
that of our first published process evaluation of the MO-
SAIC trial [19, 20], in which coding was driven by the
information obtained from the participants’ feedback.
All 82 written feedback responses were transcribed
into the software package, before being read and re-read
to familiarize the researcher with the data and allow for
initial generation of ideas. Through repeated re-reading
of the transcripts the researcher identified patterns of
common issues raised and data were systematically
coded (i.e. a code representing the most basic segment
or element of the raw data). At this early stage, as many
codes as possible were generated and collated, then
grouped into overarching themes and subthemes.
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Subsequently, codes and themes were constantly
reviewed and refined, discarded, combined or split.
Broad, higher-order themes and subthemes were la-
beled and organized to include all relevant codes.
KAZ, BR and US, researchers blind to treatment out-
come, completed data triangulations to improve validity
and reliability of the resulting themes, noting down
over-arching themes and additional ideas. They came
together to consolidate their findings, discussing any dis-
agreements until a consensus was reached. The frequen-
cies with which the codes and themes occurred were
calculated and the numbers of words in the transcripts
were counted, using the word count facility in Microsoft
Office Word 2007. The final thematic map is presented
in Fig. 1.
Global valence ratings of feedback
In a separate step, two researchers (KAZ, BR) inde-
pendently rated the overall global valence of partici-
pants’ responses on the feedback form as overall
positive, mixed or overall negative. Feedback was rated
as overall positive if the experience of therapy was de-
scribed using only favorable, approving, enthusiastic
descriptions (e.g. “BRILLIANT… Really feel that I have
been so lucky to be here and it has made all the differ-
ence between recovery and not”), as mixed if there
clearly were some positive and some negative descrip-
tions (e.g. “Mainly positive – although I don’t think it
was very positive or useful for the state I was in at the
time so didn’t make best use of the trial”), and as overall
negative if the person described their experience in
dismissive, disapproving or unenthusiastic terms (e.g.
“Useless and made me worse until landed up in hospital
again”). Seven irrelevant responses were excluded (e.g.
where participants had exclusively focused their feed-
back on the research process or were unable to give
appropriate feedback on treatment due to receiving a
very limited number of sessions). The ratings were fina-
lised when a consensus was agreed upon. These ratings
were subsequently used as comparisons between treat-
ment groups in our quantitative analyses.
Results
Quantitative analyses
114 of 142 MOSAIC participants (80.3 %) provided ac-
ceptability or credibility ratings at six- or 12-month
follow-up. There were no baseline differences in age, age
of onset, illness duration, BMI or EDE global score
between those who did (n =114) or did not (n =28) pro-
vide any feedback at 6-month or12 month follow-up. In
addition, 82 of the 142 MOSAIC participants (57.7 %)
also provided written feedback. Participants who did or
did not provide written feedback did not significantly
differ from each other on baseline demographic or clin-
ical characteristics.
A total of 60 MANTRA and 54 SSCM patients pro-
vided either quantitative and/or qualitative views on
their treatment at 6- or12-month follow-up. MANTRA
and SSCM patients who provided any feedback did not
differ significantly from each other on baseline demo-
graphic or clinical characteristics (see Table 1). A signifi-
cantly higher proportion of MANTRA patients (48/60,
Fig. 1 Thematic map of participants’ written feedback
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80 %) provided written feedback compared to those
receiving SSCM (34/54, 62.9 %) (Pearson’s Chi-Square
4.028; df =1; p = 0.045).
Whilst at six months there was no significant differ-
ence on acceptability and credibility between the two
treatments, at 12 months. MANTRA patients rated their
treatment as significantly more acceptable and credible
than SSCM patients (see Table 2).
In the written feedback, the mean number of words
used was higher in the MANTRA group (M= 107.8,
SD = 72.6) compared with the SSCM group (M= 90.6,
SD = 47.3) although this difference was not statistically
significant (t =1.296; df = 79.9; p = 0.199). After exclud-
ing participants who had given an irrelevant written
feedback response [MANTRA: 4/48 (8.3 %); SSCM: 3/
34 (8.9 %)], assessment of global valence showed that
in the MANTRA group, 35/44 participants (79.5 %)
were positive about their treatment and 9/44 (20.5 %)
either had mixed views or felt negatively about treat-
ment, whereas in the SSCM group, 19/31 (61.3 %)
were positive and 12/31 (38.7 %) mixed or negative.
Differences between the two treatments were not sig-
nificant (Pearson’s Chi-square value = 2.377; p = 0.123).
In both treatment groups, those who provided positive
feedback also gave significantly higher acceptability and
credibility ratings at 12 months than those who gave
mixed or negative feedback. In the MANTRA group,
mean acceptability ratings for participants giving positive
feedback were: M = 9.4, SD = 0.9 and for those giving
mixed or negative feedback were: M = 5.6, SD = 1.6,
(t(41) = 9.725, p < .01). Respective numbers for credibility
ratings were positive: M = 8.1, SD = 2.1; mixed or nega-
tive: M = 3.0, SD = 1.6, (t(41) = 6.956, p < .01). In SSCM,
mean acceptability ratings for people giving positive
feedback were: M = 8.6, SD = 1.5 and for those giving
mixed or negative feedback were: M = 5.8, SD = 3.2,
(t(26) = 3.160, p < .01). Respective credibility ratings were
positive: M = 7.3, SD = 1.8; mixed or negative: M = 3.1,
SD = 2.5, (t(26) = 5.307, p < .01).
Qualitative analyses
Themes were grouped according to whether they
were MANTRA-specific, SSCM-specific, or non- spe-
cific, as well as if they were positive or negative to
highlight aspects of the treatment that participants
liked or did not like. For MANTRA, specific treat-
ment features were use of the manual and exercises
and the focus on cognitive and emotional aspects of
AN. For SSCM, treatment-specific factors included
the focus on weight and eating and lack of structure.
Treatment outcomes and recovery describe the posi-
tive and negative outcomes, and stage of recovery at
the end of treatment. Non-specific factors describe
those shared between the two treatment groups such
as duration and frequency of treatment, external
support and the patient-therapist relationship. Sev-
eral similar themes were identified in Lose et al.’s
[19] paper and the same theme names have been
used here for consistency. The resulting themes and
sample quotations are presented in Table 3, and the
thematic map in Fig. 1.
Table 1 Baseline demographic and clinical characteristics of process evaluation participants split by treatment group
MANTRA SSCM t df p
n = 60 n = 54
Age (years), mean (SD) 27.0 (8.1) 25.9 (7.6) .779 112 .438
Age of onset (years), mean (SD) 17.7 (6.8) 18.6 (7.0) -.710 106 .480
Illness duration (years), mean (SD) 9.3 (8.2) 7.4 (6.8) 1.351 108 .179
EDE global score, mean (SD) 3.2 (1.3) 3.4 (1.3) -.674 112 .502
BMI (kg/m2) mean (SD) 16.7 (1.2) 16.7 (1.3) -.048 111 .961
Note. MANTRA: The Maudsley Model of Anorexia Nervosa Treatment for Adults, SSCM: Specialist Supportive Clinical Management, EDE: Eating Disorders
Examination, BMI: Body Mass Index
Table 2 Treatment acceptability and treatment credibility ratings
across six- and 12- month follow up split by treatment group
6-month follow up
MANTRA SSCM t df p
n = 55 n = 47
Treatment acceptability,
mean (SD)
8.5 (2.0) 8.0 (2.2) 1.331 100 .186
Treatment credibility,
mean (SD)
6.4 (3.1) 5.8 (2.7) 1.052 100 .295
12-month follow up
MANTRA SSCM t df p
n = 50 n = 43
Treatment acceptability,
mean (SD)
8.6 (1.8) 7.8 (2.3) 2.010 91 .047*
Treatment credibility,
mean (SD)
6.8 (3.1) 5.5 (2.7) 2.244 91 .027*
Note. *p < .05. MANTRA: The Maudsley Model of Anorexia Nervosa Treatment
for Adults, SSCM: Specialist Supportive Clinical Management, EDE: Eating
Disorder Examination, BMI: Body Mass Index
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Table 3 Themes and sample quotations based on written feedback
MANTRA
Themes and Subthemes Quotes
Treatment aspects
1. Use of manual
Positive (n = 10) M3 “Many of the exercises that we went through in the sessions made me really think about
why I felt and acted the way I did and what I really want from life.”
Negative (n = 2) M23 “I found the workbook didn’t help me as I wasn’t learning anything new.”
2. Treatment focus
Positive (n = 4) M19 “Not too focused on solely the eating disorder per se, but on the many different factors/
difficulties that encourage and maintain the eating problems (and other difficulties).”
Negative (n = 2) M43 “Did not find it that helpful. I did not feel that [the therapist] dealt with either the root of the
problem, why I lack confidence, or how to deal with it.”
Treatment outcomes and recovery
1. Positive outcomes
Effect on understanding AN symptoms and
their impact on behavior (n = 8)
M16 “[The treatment] was great in helping me to see it as a disease with symptoms as opposed
to something wrong with me as a person.”
M32 “I feel that the therapy has given me a much greater understanding of why I keep this illness
and what the illness gives me. I strongly believe that I needed this insight to be able to work on
recovery.”
Effect on feelings and thought processes
(n = 13)
M7 “I found it beneficial as I was able to start to question the [anorexic] voices and thoughts I had
regarding food – whereas before I was unable to challenge them and simply accepted them as fact.”
M41 “By no means have I completely let go of anorexia but I’ve taken so many more steps than I felt
capable of before. I have reappraised myself, my eating, and my illness and feel more hopeful than I
have in years.”
Effect on eating habits and weight (n = 7) M3 “The food plans we made also helped me to learn how to eat normally and I now rarely worry
about what I eat.”
M33 “I think strategies… help me to manage my anxiousness around food and have increased my
self-management of my food intake.”
Effect on communication (n = 3) M1 “[Expressing my feelings to others] has been really beneficial as I can tell people when I am
struggling, instead of letting the eating disorder do the talking.”
2. Negative outcomes (n = 1) M24 “I do not feel [the therapy] has necessarily AIDED recovery.”
3. Stage of recovery (n = 9) M25 “I still have my fears about gaining weight, weighing myself and find it very difficult to change.
Maybe I was/am expecting too much and there is no magic/instant cure or solution to my problems
with ED.”
M42 “I consider myself to be almost completely recovered at this point and very excited about
moving forward.”
SSCM
Treatment aspects
1. Lack of structure
Positive (n = 1) S34 “I was pleased to have been given the freedom and time to find a lot of answers and strength
for myself, but having the security of monitoring and treatment behind me.”
Negative (n = 2) S23 “I did not feel like there was a secure plan in place for that there were set goals or targets,
which I would have found helpful.”
S33 “Didn’t like the unstructured approach of SSCM, would have preferred more tailored one like
MANTRA to ensure lots of aspects of anorexia… were covered.”
2. Focus on Nutrition
Positive (n = 1) S9 “We talked a lot about food and meal plans and provided me with all the material to work out
what I needed to eat and open my eyes to what healthy eating and nutrients really mean.”
Negative (n = 4) S11 “The fact that I got weighed each week terrified me… [The therapist] started talking about 2500
calorie diet, this is when I said no I can’t do it.”
S31 “I also found the therapy too focused on food (encouragement to eat) as opposed to exploring
feeling and behaviors. I would have liked to explore why I do this to myself. I am still struggling to
understand this.”
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MANTRA
Treatment aspects
Use of manual
Positive Ten participants gave positive comments
about the MANTRA manual and its exercises. They
remarked on its flexibility and ability to be tailored to
their needs. Participants also felt that the resources
were enjoyable to use, helped them gain better under-
standing of their illness and provided them with skills
to facilitate change. They valued the focused tasks
and useful analogies in aiding their reflection and re-
covery. Even though two participants found the exer-
cises “repetitive” (M20) or “uncomfortable to do”
(M16), they indicated that they understood the im-
portance of the issues addressed.
Negative Two participants did not find the manual
useful, as they felt that the exercises were too diffi-
cult, or that they did not learn anything new from
the resources.
Table 3 Themes and sample quotations based on written feedback (Continued)
Treatment outcomes and recovery
1. Positive outcomes
Effect on understanding AN symptoms
and their impact on behavior (n = 4)
S7 “I do feel that the therapy has given me a better foundation and understanding of my
behavior to work from.”
S31 “During the therapy I became aware of my issues and realized that most of my physical
problems are due to the same issue.”
Effect on feelings and thought processes
(n = 1)
S26 “I hope it has set me up with the right mental tools to be able to analyze situations better (both
related and unrelated to food).”
Effect on eating habits and weight
(n = 2)
S27 “I still have a lot of negative eating disordered thoughts but I’m at a healthy weight so I suppose
that is a positive.”
Effect on communication (n = 2) S30 “Felt that I could be very open and honest even when I knew what I was feeling or saying
would expose my underlying desire to keep my eating disorder.”
2. Negative outcomes (n = 2) S1 “Anything new I have tried I have not tried more than once or made a permanent part of my
diet… And sometimes I feel I say or agree to things just to please my therapist.”
S33 “Ended up being admitted as an inpatient due to low mood and then daycare treatment for
[eating disorders].”
3. Stage of recovery (n = 4) S17 “I felt like the therapy did not get very far… I don’t know if any therapy can ever stop [the
illness].”
S26 “I hope with carrying on the therapy for a bit I will be able to return to eating healthily.”
Non-specific
1. Duration, frequency and disruptions
of therapy (n = 11)
M12 “I do not feel that it was long enough and I have definitely regressed.”
S14 “I found it difficult to maintain changes to my diet only seeing the therapist once a week,
perhaps more regular appointments would help people continue their recovery independently.”
S12 “Unfortunately, my therapist was away for quite a few weeks during my weekly sessions and this
did set me back a bit, and feel I still have quite a way to go.”
2. External social support (n = 9) S31 “It was very useful to have my family involved in the therapy.”
S21 “I would have liked to have group sessions so I didn’t feel so abnormal about thoughts I was
having.”
3. Pacing and individualization
of treatment (n = 8)
M27 “I appreciated the way it was individualized and went at the pace that suited me.”
S11 “I think a slower pace, I was not at all ready mentally to increase food.”
4. Therapist (n = 31) M7 “My psychologist was fantastic with me. I feel I learned a lot from her and even though I have
now stopped seeing her, I still remember a lot of what we covered and can use it to continue
challenging my thoughts.”
S7 “After developing a therapist/patient relationship… I was able to feel as though I could trust her
advice over my thoughts.”
M48 “The therapist I was given I believe failed to deliver this treatment in an acceptable and
appropriate manner.”
5. Concerns about ending therapy (n = 9) M44 “I notice an immediate change back to some old behaviors within two weeks of ceasing weekly
sessions.”
S27 “I am scared of getting ill again.”
Note. MANTRA: The Maudsley Model of Anorexia Nervosa Treatment for Adults, SSCM: Specialist Supportive Clinical Management
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Treatment focus
Positive Four participants felt that MANTRA’s focus on
cognitive, emotional and interpersonal factors, instead of
primarily nutrition, helped them better understand their
illness.
Negative In contrast, one participant reported that
MANTRA did not address the issue of self-confidence
which she felt was key for her illness and another would
have preferred more help with nutrition.
Treatment outcomes and recovery
Positive outcomes
Effect on understanding ED symptoms and their im-
pact on behaviour Eight participants said that they had
benefited from acquiring a greater understanding of AN
and of themselves, including the factors contributing to
AN, symptoms and their negative impact on their life.
Participants were able to see AN as an illness with
symptoms separate from their identity. Reflection also
helped them to identify, face, and tackle issues from
their past and present. Participants highlighted that
these factors helped them in their recovery.
Effect on feelings and thought processes Thirteen
participants also referred to ways in which the treat-
ment contributed to altered ways of thinking, re-
appraising their approach to situations in a more
adaptive way. This enabled them to challenge negative
thoughts, reduce anxiety, accept weight gain, and gain
confidence in recovery.
Effect on eating habits and weight Seven participants
described positive changes in their eating and weight
and linked this to other improvements in their life,
such as resuming their education and boosting their
self-confidence.
Effect on communication Three participants indicated
greater expression of feelings towards others around
them, enabling them to open up about their illness to
close others.
Negative outcomes
One participant commented that the treatment did not
help with her recovery but did not elaborate as to why
this was the case.
Stage of recovery
Several MANTRA participants commented on their
stage of recovery. Two conveyed that they still had diffi-
culties with eating, weight gain, and relationships with
others. Even though they acknowledged they had not
attained full recovery, seven participants expressed hope
and excitement, as well as the recognition that recovery
would be a difficult but not insurmountable challenge.
SSCM
Treatment aspects
Two distinct features of SSCM were highlighted by pa-
tients: focus on weight and eating and its lack of
structure.
Lack of structure
Positive One participant liked the freedom associated
with the treatment, as it enabled her to express herself
fully with the guidance of the therapist.
Negative Two participants disliked the lack of treatment
structure, and would have preferred a more structured
and comprehensive approach.
Focus on nutrition
Positive One participant found SSCM’s focus on weight
and eating favourable in supporting recovery.
Negative Four participants indicated that the focus on
weighing and nutritional advice was distressing or un-
suitable for their needs. They stated that a focus on
other aspects of AN, such as body image, or its emo-
tional and psychological aspects would have been
preferable.
Treatment outcomes and recovery
Positive outcomes
Effect on understanding ED symptoms and their im-
pact on behaviour Four SSCM patients expressed that
they had gained greater understanding of AN and of
themselves, which helped them identify problems that
needed addressing.
Effect on feelings and thought processes One partici-
pant indicated that they experienced altered ways of
thinking, in terms of an improved ability to analyse situ-
ations and to positively compare themselves to others.
Effect on eating habits and weight Two participants
described achieving normal eating, weight gain, and a
greater understanding and respect for their body.
Effect on communication Two participants found the
therapy useful in encouraging expression of feelings to-
wards the therapist and close others.
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Negative outcomes
Two SSCM patients felt that the treatment did not bene-
fit them as they required an additional inpatient
admission.
Stage of recovery
Four participants shared their outlook regarding their
own recovery. One expressed hopefulness about healthy
eating, whilst the other three expressed that the therapy
did not enable them to achieve long-lasting changes or
that recovery was perceived to be impossible.
Non-specific factors
Duration, frequency and disruptions in treatment
Eight participants (M = 5, S = 3) commented on the
duration of treatment and frequency of therapy ses-
sions, with some (M = 1) being satisfied and others
(M = 4, S = 3) wishing for a greater number or fre-
quency of sessions. Three participants (M = 1, S = 2)
were dissatisfied about temporary disruptions in
their therapy that they felt had contributed to their
condition worsening.
External social support
Participants valued the importance of social support
during their therapy and recovery. Five (M = 4, S = 1) in-
dividuals felt that more involvement of family members
and close others would have been beneficial. Four partic-
ipants (M = 1, S = 3) suggested that the involvement of
other currently ill or recovered AN patients could serve
as friends who truly understood their illness and provide
role models for recovery.
Pacing and individualisation of treatment
Five participants (M = 4, S = 1) commented that their
treatment was flexible, individualized and relevant for
their needs. This included the flexibility of treatment,
meeting with a dietician for nutritional advice, and treat-
ment moving at a comfortable pace. Three participants
(M = 1, S = 2), however, felt that their treatment was not
individualized enough.
Therapist
A total of 31 participants (M = 21, S = 10) mentioned their
therapists in their written feedback; 27 (M = 19, S = 8) gave
positive comments, including favorable qualities, such as
being understanding, sympathetic, non-judgmental, kind,
considerate to their needs, welcoming, intuitive, compas-
sionate, and empathic. Furthermore, they also commented
on the therapists’ expertise, and the development of the
therapist-patient relationship. Three participants (M = 1,
S = 2), however, expressed dissatisfaction about a change
of therapist and disrupted therapy, and one MANTRA
patient felt that their therapist lacked training in conduct-
ing the treatment.
Concerns about ending therapy
Several participants (M = 7, S = 2) expressed concerns
about ending therapy, including fear of returning to old
behaviours and suggested including more follow-up
support.
Discussion
This study is the second stage of a process evaluation in-
tegrated into a large scale RCT of two outpatient psy-
chological therapies in adults with AN. This evaluation
combined the use of both quantitative and qualitative
measures to assess patients’ treatment experiences.
Findings show that at 12 months post-randomisation
i.e. at the end of both weekly and follow up treatment
sessions, MANTRA patients rate their treatment as sig-
nificantly more acceptable and credible than patients re-
ceiving SSCM. This result is strengthened by the clear
agreement between the global valence of the qualita-
tive written feedback and quantitative VAS ratings at
12-month follow-up, in that participants who pro-
vided overall positive written feedback also rated their
treatment as significantly more acceptable and cred-
ible than participants who gave mixed or negative
written feedback.
It is also of note that, although overall proportions of
MANTRA and SSCM patients who provided some
process feedback did not differ, significantly more MAN-
TRA patients gave written feedback when compared to
SSCM. Those MANTRA patients who did respond also
tended to give a more detailed account of their experi-
ences (as assessed by number of words used). This
difference might be explained by the fact that MANTRA
aims to reduce AN patients’ emotion avoidance and sup-
pression, and to increase emotional clarity and adaptive
emotion regulation, such as emotional expressivity [27].
Arguably willingness to express views about one’s treat-
ment experience is a facet of this. Alternatively, it may
be that MANTRA patients are simply more practiced in
using writing as a form of expression compared to
SSCM patients, given that therapeutic writing exercises
are incorporated into this treatment, but not into SSCM.
Overall, themes that arose from the thematic analysis
replicate those found in our earlier paper which used
qualitative interviews in a subset of patients from one
participating centre [19]. Participants highlighted both
treatment specific (e.g. MANTRA: manual, exercises,
comprehensive focus; SSCM: focus on nutrition, lack of
structure) and non-specific factors (e.g. relationship with
therapist, treatment pacing, duration, frequency and dis-
ruption, external social support and concerns about end-
ing therapy) as important aspects of their treatment.
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Thus MANTRA and SSCM were experienced somewhat
differently in terms of their focus, strengths and chal-
lenges, but there were also some overlapping features.
The perceived differences between treatments, both
positive and negative, were to an extent, in line with the
specific focus and targets of each treatment. MANTRA
targets motivational, cognitive, emotional and interper-
sonal maintaining factors of AN with the aim of effect-
ing nutritional changes via broader cognitive and
emotional changes. In contrast, SSCM centrally focuses
on improving eating and weight and other topics for dis-
cussion arise as chosen by patients, session by session.
Thus, in MANTRA many participants valued the flex-
ible, individually tailored manual-based approach and
the focus on thoughts and feelings. A small number of
patients however, experienced certain therapeutic exer-
cises as unhelpful or even as patronising, and felt the
manual-based approach did not address their unique
problems or teach them anything new. Whilst these
more critical views may be legitimate and appropriate
there is a possibility that they may at least in part be
linked to AN patients’ detail-focused perfectionist cogni-
tive style, that makes some individuals dismissive of any-
thing that is not a perfect fit. It is important for
therapist to be aware of this possibility.
In SSCM, patients who gave positive feedback com-
mended the clear focus on nutrition and freedom of-
fered, whereas others saw the focus on nutrition as
negative, generating anxiety and distress. SSCM’s lack of
structure was also seen as unhelpful by some, in facilitat-
ing exploration of certain aspects of their illness.
In addition, across treatment groups disappointment
regarding failure to reach desired improvements or a
continuation of significant ED symptoms associated with
more negative feedback. Thus mixed or negative feed-
back about treatment appeared to be due to a range of
reasons, some to do with the therapeutic focus, content,
delivery or structure, others with patients’ mixed feelings
about change or disappointment about limited progress.
As expected, due to feedback being collected at the
end of treatment the theme of recovery and life beyond
therapy was more prominent in the present evaluation
than in our earlier interview study [19]. More MANTRA
patients addressed this issue than those receiving SSCM.
In general, MANTRA patients expressed greater satis-
faction with their progress and excitement about work-
ing towards their future, despite the recognition that
achieving recovery would remain challenging. Of the few
SSCM patients mentioning this theme one individual
expressed pessimism about recovery whilst the other
remained hopeful.
Several non-specific factors were mentioned by a sub-
stantial number of patients. This suggests the import-
ance of basic factors such as structure, duration and
timing for the success of a treatment and the difficulties
that arise from disruptions through therapist illness or
departure. The single most commonly mentioned
theme by a long way, unsurprisingly was that of the
therapeutic relationship A previous study on therapist
characteristics preferred by AN patients identified fac-
tors (acceptance, vitality, challenge and expertise)
associated with a good therapeutic relationship and
also unhelpful therapist characteristics (disregard,
prejudice, passivity, pampering) [28]. The views of pa-
tients in the present study largely confirm these find-
ings. Overall, our findings support the implications
highlighted in the earlier process evaluations of the
MOSAIC Trial [19, 20]. More specifically, the import-
ance of non- specific factors, such as therapist charac-
teristics, individualisation of treatment and social
support are emphasized.
Since the completion of the process study, the study’s
main outcomes have been published [18]. Findings show
that MANTRA patients attended significantly more
treatment sessions and a higher proportion of MAN-
TRA patients were treatment completers. Whilst overall
there were no significant differences at 12 months be-
tween MANTRA and SSCM on BMI, eating disorders
psychopathology, distress levels and other outcomes,
MANTRA appeared to be advantageous in more under-
weight patients in terms of facilitating greater weight
gain at both 6 and 12 months. This suggests that MAN-
TRA patients’ view of this treatment as more acceptable,
credible and all round positive is at least in part rooted
in better clinical outcomes.
The ‘three-legged stool’ principle of evidence-based
medicine [29, 30] suggests that in choosing one inter-
vention over another, best available research evidence
about efficacy, clinical expertise and patient preference
all need to be considered. With this in mind MANTRA
can be recommended over SSCM.
Finally, due to the more positive initial treatment ex-
perience, individuals’ receiving MANTRA may be more
willing to have further treatment should this become ne-
cessary. This is particularly important for the many indi-
viduals with AN who have a chronic and/or relapsing
course of the illness.
This study has several strengths and limitations.
Firstly, over 80 % of MOSAIC trial participants provided
some process feedback and there were no baseline differ-
ences between those who did and did not provide these
data. Thus, our findings are likely to be representative of
the views shared by the whole MOSAIC trial sample.
Secondly, treatment acceptability and credibility ratings
were supported by the written feedback provided.
Thirdly, participants were recruited from all treatment
sites involved in the MOSAIC trial and data were ob-
tained and analysed before trial outcomes are known.
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Finally, bias in the interpretation of qualitative data was
reduced through performing data triangulations.
The study also has a number of limitations. First, a sig-
nificantly higher proportion of MANTRA patients com-
pared to SSCM patients provided written feedback. The
fact that the SSCM group were more selected may have
biased the results. Second, although the use of written
feedback, enabled participants to express their opinions
freely and independently (i.e. away from their thera-
pists’), the questions asked were broad and the written
nature of the feedback did not allow for probing and
exploration of key issues as a qualitative interview
would. It might have been helpful to include detailed
questions in order to obtain more in-depth feedback
regarding different treatment components and out-
comes. Third, the feedback represents participants’
retrospective recollections of treatment at the time point
of assessment, and there may have been some recall bias.
However, this would have operated similarly in both
treatments. Fourth, some of the qualitative themes were
only reported by one or two participants. Thus caution
is required in interpretation of these findings. Nonethe-
less, current results replicate those obtained from semi-
structured interviews carried out as part of the previous
evaluation [19].
Fifth, our assessment of credibility was limited to help-
fulness of treatment and thus rather narrow. Established
expectancy/credibility scales [25] also include other
aspects, such as how logical a particular therapy ration-
ale seems to the patient and whether they would recom-
mend a treatment to a friend or another person in their
situation. It is possible that use of a broader credibility
scale would have yielded different responses.
A final limitation is the lack of a treatment expect-
ancy measure taken at the start of therapy. However,
in the previous pilot trial comparing MANTRA with
SSCM a treatment expectancy measure was included
and both treatments were viewed as equally credible
and positive [15].
Conclusions
Together with our earlier interview paper [19] on pa-
tients’ views of their treatment this study is very much a
first attempt to capture some of the qualitative views of
patients receiving the two study treatments and is some-
what exploratory in its nature. MANTRA patients
viewed their treatment as more acceptable, credible and
generally more positive in comparison to patients receiv-
ing SSCM at 12 months. Participants also highlighted
the useful components of and outcomes associated with
their treatment. MANTRA patients valued the use of
the manual and the focus on cognitive, emotional and
interpersonal factors, while SSCM patients mentioned
its less structured nature and focus on nutrition. This
study, together with the previous process evaluation
[19], suggests that many individuals with AN perceive
MANTRA as a viable treatment option. Further studies
should include more sophisticated methods of evaluating
treatment process to address the dearth of research in
this area.
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